|
EVALUATION
In consideration of the knowledge of the patient; the knowledge, capability and experience of the attending physician; and the availability and use of the most up-to-date equipment; a complete evaluation should be undertaken with a written report furnished to the patient outlining ALL treatment options available – not those that serve only the vested interest of the physician.
Improvements in ultrasound equipment, namely Doppler Color Enhancement, permits a more definable hypoechoic echogenicity that makes it possible to provide a needle guided biopsy rather than blinded multiple randomized biopsies, which may miss the tumors entirely especially when they are small.
Imaging enhancement with the use of CT scans and MRI’s can authenticate the presence of extracapsular tumors and confirm metastases.
Other evaluation procedures should be taken to provide additional data, such as the pH values and a ploidy analysis that indicates the aggressiveness of the disease. Diploid designating nonaggressive disease, with aneuploid or tetraploid characteristics indicating more aggressive disease.
Comparing the PSA value with the Partin Tables can give clues as to whether the disease is localized or systemic. |
|
“Let’s Conquer Prostate Cancer In OUR Lifetime” |
|
PAACT Inc. (Patient Advocates for Advanced Cancer Treatments) PO Box 141695 Grand Rapids, MI 49514
1143 Parmelee Ave NW Grand Rapids, MI 49504 |
|
To contact us: |
